Changes in TLR2 and TLR4 gene expression in patients with ischemic stroke


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. The study of atherosclerosis and its complications is one of the priority areas of scientific research in the field of neurology and fundamental sciences. A lot of research has expanded the understanding of the involvement of the immune response, inflammatory reactions in the pathogenesis of ischemic stroke (IS). New information about the role of innate immunity in the brain response to ischemia is emerging. Objective. Determination of the TLR2 and TLR4 gene expression in patients with IS and healthy individuals. Methods. The study included 28 patients with ischemic stroke and a comparison group consisting of 18 healthy individuals. Results. It was found that the TLR4 gene expression significantly exceeded the TLR2 gene expression on days 1, 3, and 7 after the onset of IS. It was shown that on the 1st day of disease, the expression of the studied genes significantly exceeded their expression in the control group. At the same time, on the 3rd day, the TLR2 and TLR4 gene expression somewhat decreased. However, on the 7th day, an increase in expression was noted again. The available literature data suggest that the decrease in the TLR2 and TLR4 gene expression on the 3rd day after the onset of a stroke may be associated with the implementation of neuroprotection mechanisms, in which HSP70, HSP27, miR-21, miR-24, and miR- 223 can play a leading role. Increased TLR2 and TLR4 gene expression on day 7 may be associated with delayed death of brain cells in the postischemic period. Conclusion. The study obtained data on changes in the TLR2 and TLR4 gene expression in patients with IS over time, which makes it possible to assess changes in the activity of the inflammatory process in them at the system level. TLRs make a great contribution to the course of IS, which justifies the need for further research into the role of innate immunity in the development of IS in order to elaborate and implement new approaches to prognosis and therapy.

Full Text

Restricted Access

About the authors

E. A Koltsova

Pirogov Russian National Research Medical University

Department of Neurology, Neurosurgery and Medical Genetics, Faculty of General Medicicne Moscow, Russia

Elizaveta A. Petrova

Pirogov Russian National Research Medical University

Email: 6332011@mail.ru
Department of Neurology, Neurosurgery and Medical Genetics, Faculty of General Medicine Moscow, Russia

V. V Grechenko

Pirogov Russian National Research Medical University

Department of Immunology, Biomedical Faculty Moscow, Russia

L. V Gankovskaya

Pirogov Russian National Research Medical University

Department of Immunology, Biomedical Faculty Moscow, Russia

References

  1. Понасенко А.В., Хуторная М.В., Кутихин А.Г. и др. Роль полиморфизмов генов семейства Toll-подобных рецепторов в атеросклеротическом поражении сосудов сердца. Атеросклероз. 2015;11(3):22-8
  2. Lee C.C, Avalos A.M., Ploegh H.L. Accessory molecules for Toll-like receptors and their function. Nat Res Immunol. 2012;12(3):168-79. doi: 10.1038/nri3151.
  3. McGettrick A.F., O'Neill L. Localisation and trafficking of Toll-like receptors: an important mode of regulation. Curr Opin Immunol. 2010;22(1):20-7. Doi: 10.1016/j. coi.2009.12.002.
  4. Жидкова И.И, Понасенко А.В., Хуторная М.В. и др. Генетические факторы (гены рецепторов врожденного иммунитета - TLRs) в патогенезе атеросклероза и его осложнений. Медицинская иммунология. 2017;19(3):241-54.
  5. Libby P, Okamoto Y., Rocha V.Z., Folco E. Inflammation in atherosclerosis: transition from theory to practice. Circ J. 2010;74(2):213-20. doi: 10.1253/circj.cj-09-0706.
  6. Ionita M, Arslan F, de Kleijn D., Pasterkamp G. Endogenous inflammatory molecules engage Toll-like receptors in cardiovascular disease. J Innate Immun. 2010;2(4):307-15. doi: 10.1159/000314270.
  7. McCarthy C.G., Goulopoulou S., Wenceslau C.F., et al. Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension. Am J Physiol Heart Circ Physiol. 2014;306(2):184-96. doi: 10.1152/ajpheart.00328.2013.
  8. Seneviratne A.N., Sivagurunathan B., Monaco C. Toll-like receptors and macrophage activation in atherosclerosis. Clin Chim Acta. 2012;413(1-2):3-14. doi: 10.1016/j.cca.2011.08.021.
  9. Visintin A., Mazzoni A., Spitzer J.H., et al. Regulation of Toll-like receptors in human monocytes and dendritic cells. J Immunol. 2001;166(1):249-55. Doi: 10.4049/ jimmunol.166.1.249.
  10. Барбараш О.Л., Головкин А.С., Понасенко А.В. и др. Роль полиморфизма генов Toll-подобных рецепторов в развитии осложнений атеросклероза. Российский кардиологический журнал. 2015;12:72-9.
  11. Скворцова В.И., Шурдумова М.Х., Константинова Е.В. Значение Toll-подобных рецепторов в развитии ишемического повреждения. Журнал неврологии и психиатрии имени С.С. Корсакова. 2010;110(4(2)):12-7
  12. Ковальчук Л.В., Хорева М.В., Варивода А.С. и др. Роль рецепторов врожденного иммунитета в развитии острого инфаркта миокарда. Журнал микробиологии, эпидемиологии и иммунологии. 2008;4:64-8
  13. Sheu J.J., Chang L.T., Chiang C.H., et al. Prognostic value of activated toll-like receptor-4 in monocytes following acute myocardial infarction.Int Heart J. 2008;49(1):1-11. doi: 10.1536/ ihj.49.1.
  14. Константинова Е.В., Кочетов А.Г., Шостак Н.А. и др. Особенности иммунного ответа и воспалительной реакции при атеротромботическом инсульте и инфаркте миокарда. Журнал неврологии и психиатрии им. С.С. Корсакова. 2015;12(2):48-53.
  15. Wang Y., Ge P, Zhu Y TLR2 and TLR4 in the Brain Injury Caused by Cerebral Ischemia and Reperfusion. Mediators Inflamm. 2013;2013:124614. doi: 10.1155/2013/124614.
  16. Шертаев М.М., Ибрагимов У.К., Икрамова С.Х. и др. Морфологические изменения в тканях головного мозга при экспериментальной ишемии. Вестник НГПУ. 2015;23:73-7.
  17. Баринов Э.Ф., Евтушенко С.К., Максименко Т.Л. и др. Механизмы регуляции воспаления в ишемизированном мозге. Международный неврологический журнал. 2013;8(62):17
  18. Kim J.Y., Han Y., Lee J.E., Yenari M.A. The 70-kDa heat shock protein (Hsp70) as a therapeutic target for stroke. J Expert Opin Ther Targets. 2018;22(3):191-199. doi: 10.1080/14728222.2018.1439477.
  19. Zhou J., Zhang J. Indefication of miRNA-21 and miRNA-24 in plasma as potential early stage markers of acute cerebral infarction. Mol Med Rep. 2014;10(2):971-6. Doi: 10.3892/ mmr.2014.2245.
  20. Абатуров А.Е., Волосовец А.П., Юлиш Е.И. Роль Toll-подобных рецепторов в рекогниции патоген-ассоциированных молекулярных структур инфекционных патогенных агентов и развитии воспаления. Часть 2. Лиганды TLR. Здоровье ребенка. 2012;6(41):213-17.
  21. Shichita T, Ito M., Yoshimura A. Post-ischemic inflammation regulates neural damage and protection. Front Cell Neurosci. 2014;8:319. doi: 10.3389/fncel.2014.00319.
  22. Щербак Н.С. Эффекты и механизмы ишемического прекондиционирования и посткондиционирования головного мозга. Дисс. докт. биол. наук. СПб., 2016. С. 22-74.
  23. Беленичев И.Ф. Роль белков теплового шока в реализации молекулярно-биохимических механизмов нейропротекции. Фармакология и лекарственная токсикология. 2013;6(36):72-80
  24. Lackie R.E., Maciejewski A., Ostapchenko V.G., et al. The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases. Front Neurosci. 2017;11:254. doi: 10.3389/ fnins.2017.00254
  25. Sharp F.R., Zhan X., Liu D.Z. Heat Shock Proteins in the Brain: Role of Hsp70, Hsp 27 and HO-1 (Hsp32) and Their Therapeutic Potential. J Translational Stroke Research. 2013, p. 686-90.
  26. Brea D., Agulla J., Staes A., et al. Study of Protein Expresion in Peri-Infarct Tissue after Cerebral Ischemia. Sci Rep. 2015;5:12030. doi: 10.1038/srep12030.
  27. Локтионова С.А. Защита эндотелиальных клеток сосудов человека от повреждения при ишемии in vitro: Роль белка теплового шока HSP27. Д. канд. биол. наук. Москва, 1998. C. 10-8.
  28. Liu W., Chen X., Zhang Y. Effects of mocroRNA-21 and microRNA-24 inhibitors on neuronal apoptosis in ischemic stroke. Am J Transl Res. 2016;8(7):3179-87.
  29. Новикова Л.Б., Минибаева Г.М. Роль микроРНК в патогенезе ишемического инсульта. Журнал неврологии и психиатрии им. С.С. Корсакова. 2018;2:44-6.
  30. Сторожевых Т.П. Механизмы нарушения систем транспорта кальция в нейронах мозга при действии глутамата. Дисс. докт. биол. наук. Москва, 2002. С. 26-34.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies